Susan Abedi, chief strategy officer, 81qd-MKG

Most recent articles by Susan Abedi, chief strategy officer, 81qd-MKG

Chem 101: An HCP affinity data lab

September 12, 2023

10:00 am

It’s time to expand our approach to assessing HCP affinity. A chemistry lesson can help.

From Our Partners

Partner Content

Will pharma finally reach out to minorities before the government forces their hand?

Why must the pharma industry consistently be positioned as an opponent? The government should seek “win-win” situations rather than “victories over …” situations. We still have a long way to go.

Partner Content

3 reasons the point of care is key for improving medication adherence

To overcome adherence obstacles, support needs to begin the moment a prescription is written and continue throughout the patient journey.

Partner Content

Laser focus your strategy: Data-driven marketing for oncology and rare diseases

How to use audience data to take your targeting capabilities to the next level.

Partner Content

The transformative impact of telehealth and point-of-care on healthcare marketing

Delivering educational content where and when it matters most.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Susan Abedi, chief strategy officer, 81qd-MKG

Most recent articles by Susan Abedi, chief strategy officer, 81qd-MKG

Chem 101: An HCP affinity data lab

The MM+M Media Summit

From Our Partners

Partner Content

Will pharma finally reach out to minorities before the government forces their hand?

Partner Content

3 reasons the point of care is key for improving medication adherence

Partner Content

Laser focus your strategy: Data-driven marketing for oncology and rare diseases

Partner Content

The transformative impact of telehealth and point-of-care on healthcare marketing

Thank you for accessing MM+M.